 |
|
Consolidation Therapies In Ovarian Cancer Presented by Paul Sabbatini, MD
Runtime: 23 minutes |
|
This CME activity is directed toward all physicians involved in the treatment of patients with ovarian cancer. This activity will provide participants with an overview of consolidation therapies in ovarian cancer and the reasons why the second remission population is important to focus upon. The majority of consolidation therapies to date have been applied in first remission. The second remission population is ideal in which to study multiple new agents but population needs further characterization. The ultimate goal of the activity is to improve the care provided to ovarian cancer patients.
Please read this page completely before beginning the activity. If you have any questions or need further information, please call the Memorial Sloan-Kettering Cancer Center's CME Office at 646-227-2025.
Watch Video
Course Information
-
Speaker:
-
Target Audience
This CME activity is directed toward all physicians involved in the treatment of patients with ovarian cancer.
-
CME Credit
Memorial Sloan-Kettering Cancer Center designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
-
Educational Objectives
This activity will provide participants with an overview of consolidation therapies in ovarian cancer and the reasons why the second remission population is important to focus upon. The majority of consolidation therapies to date have been applied in first remission. The second remission population is ideal in which to study multiple new agents but there is an educational gap in that the second remission population needs further characterization. The ultimate goal of the activity is to improve the care provided to ovarian cancer patients.
-
Evaluation
A course evaluation form will provide attendees with the opportunity to review the sessions and the speakers and to identify future educational needs.
Poilicies
-
Accreditation
Memorial Sloan-Kettering is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.
-
Disclosure
Memorial Sloan-Kettering relies upon faculty participants in its CME Program to provide educational information that is objective and as free from bias as possible. In accordance with the nationally accepted guidelines, faculty are asked to indicate any commercial relationship that might be perceived as a real or apparent conflict of interest.
All faculty for this activity have indicated that they have no commercial relationships to disclose to the audience.
-
Commercial Support
There is no commercial support provided for this CME activity.
